Role of KSRP in control of type i interferon and cytokine expression

Journal of Interferon and Cytokine Research

Volumn 34, Issue 4, 2014, Pages 267-274

  King, Peter H ^a,b   Chen, Ching Yi ^c  

^a University of Alabama at Birmingham   (United States)

^b Veterans Affairs Medical Research Center   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERFERON STIMULATED GENE FACTOR 3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 16; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; INTERLEUKIN 8; KH TYPE SPLICING REGULATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; PROTEIN C FOS; RANTES; REGULATOR PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRISTETRAPROLIN; UNCLASSIFIED DRUG; KHSRP PROTEIN, HUMAN; MICRORNA; RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

3' UNTRANSLATED REGION; AU RICH ELEMENT; DOWN REGULATION; GENE CONTROL; GENETIC STABILITY; HUMAN; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN TARGETING; REVIEW; RNA STABILITY; VIRUS INFECTION; ANIMAL; AUTOIMMUNITY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASM; RNA INTERFERENCE;

ANIMALS; AUTOIMMUNITY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOMODULATION; INFLAMMATION; INTERFERON TYPE I; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASMS; RNA INTERFERENCE; RNA-BINDING PROTEINS; TRANS-ACTIVATORS;

EID: 84898730719     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0143     Document Type: Review

References (72)

1. Abdelmohsen K, Yuki K, Kim HH, Gorospe M. 2008. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 389(3):243-255.
2. Anderson P. 2008. Post-transcriptional control of cytokine production. Nat Immunol 9(4):353-359.
3. Anderson P. 2010. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 10(1):24-35.
4. Asirvatham AJ, Magner WJ, Tomasi TB. 2009. miRNA regulation of cytokine genes. Cytokine 45(2):58-69.
5. Bakheet T, Williams BR, Khabar KS. 2006. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34(Database issue):D111-D114.
6. Banchereau J, Pascual V. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25(3):383-392.
7. Barreau C, Paillard L, Osborne HB. 2005. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33(22):7138-7150.
8. Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A. 2003. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195(3):356-372.
9. Bhattacharyya S, Balakathiresan NS, Dalgard C, Gutti U, Armistead D, Jozwik C, Srivastava M, Pollard HB, Biswas R. 2011. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J Biol Chem 286(13):11604-11615.
10. Bhattacharyya S, Kumar P, Tsuchiya M, Bhattacharyya A, Biswas R. 2013. Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNAdestabilizing proteins, KSRP and TTP. Biochem Biophys Res Commun 433(4):484-488.
11. Blackshear PJ. 2002. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans 30(Pt 6):945-952.
12. Bouchon A, Facchetti F, Weigand MA, Colonna M. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410(6832):1103-1107.
13. Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, Puri PL, Gherzi R. 2005. p38-Dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 20(6):891-903.
14. Briata P, Ilengo C, Corte G, Moroni C, Rosenfeld MG, Chen CY, Gherzi R. 2003. The Wnt/beta-catenin- Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs. Mol Cell 12(5):1201-1211.
15. Briata P, Lin WJ, Giovarelli M, Pasero M, Chou CF, Trabucchi M, Rosenfeld MG, Chen CY, Gherzi R. 2012. PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death Differ 19(3):478-487.
16. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J, Clark AR. 2006. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 26(6):2408-2418.
17. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M, Karin M. 2001. AU binding proteins recruit the exosome to degrade AREcontaining mRNAs. Cell 107(4):451-464.
18. Chen CY, Shyu AB. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20(11):465-470.
19. Davis-Smyth T, Duncan RC, Zheng T, Michelotti G, Levens D. 1996. The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. J Biol Chem 271(49):31679-31687.
20. Dhamija S, Kuehne N, Winzen R, Doerrie A, Dittrich-Breiholz O, Thakur BK, Kracht M, Holtmann H. 2011. Interleukin-1 activates synthesis of interleukin-6 by interfering with a KH-type splicing regulatory protein (KSRP)-dependent translational silencing mechanism. J Biol Chem 286(38):33279-33288.
21. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36(2):180-190.
22. Duncan R, Collins I, Tomonaga T, Zhang T, Levens D. 1996. A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP. Mol Cell Biol 16(5):2274-2282.
23. Esclatine A, Taddeo B, Roizman B. 2004. Herpes simplex virus 1 induces cytoplasmic accumulation of TIA-1/TIAR and both synthesis and cytoplasmic accumulation of tristetraprolin, two cellular proteins that bind and destabilize AU-rich RNAs. J Virol 78(16):8582-8592.
24. Espel E. 2005. The role of the AU-rich elements of mRNAs in controlling translation. Semin Cell Dev Biol 16(1):59-67.
25. Fechir M, Linker K, Pautz A, Hubrich T, Forstermann U, Rodriguez-Pascual F, Kleinert H. 2005. Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol Pharmacol 67(6):2148-2161.
26. Garcia-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312(5775):879-882.
27. Gherzi R, Lee KY, Briata P, Wegmuller D, Moroni C, Karin M, Chen CY. 2004. A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell 14(5):571-583.
28. Gherzi R, Trabucchi M, Ponassi M, Ruggiero T, Corte G, Moroni C, Chen CY, Khabar KS, Andersen JS, Briata P. 2006. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol 5(1):e5.
29. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36(2):166-174.
30. Grafi G, Sela I, Galili G. 1993. Translational regulation of human beta interferon mRNA: association of the 3¢ AU-rich sequence with the poly(A) tail reduces translation efficiency in vitro. Mol Cell Biol 13(6):3487-3493.
31. Graham JR, Hendershott MC, Terragni J, Cooper GM. 2010. mRNA degradation plays a significant role in the program of gene expression regulated by phosphatidylinositol 3-kinase signaling. Mol Cell Biol 30(22):5295-5305.
32. Hamilton TA, Novotny M, Datta S, Mandal P, Hartupee J, Tebo J, Li X. 2007. Chemokine and chemoattractant receptor expression: post-transcriptional regulation. J Leukoc Biol 82(2):213-219.
33. Herjan T, Novotny M, Hamilton TA. 2013. Diversity in sequence-dependent control of GRO chemokine mRNA halflife. J Leukoc Biol 93(6):895-904.
34. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M. 2006. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 26(6):2399-2407.
35. Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25(3):349-360.
36. Khabar KS. 2007. Rapid transit in the immune cells: the role of mRNA turnover regulation. J Leukoc Biol 81(6):1335-1344.
37. Khabar KS, Young HA. 2007. Post-transcriptional control of the interferon system. Biochimie 89(6-7):761-769.
38. Klesney-Tait J, Turnbull IR, Colonna M. 2006. The TREM receptor family and signal integration. Nat Immunol 7(12): 1266-1273.
39. Kruys V, Wathelet M, Poupart P, Contreras R, Fiers W, Content J, Huez G. 1987. The 3¢ untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. Proc Natl Acad Sci USA 84(17):6030-6034.
40. Li X, Lin WJ, Chen CY, Si Y, Zhang X, Lu L, Suswam E, Zheng L, King PH. 2012. KSRP: a checkpoint for inflammatory cytokine production in astrocytes. Glia 60(11):1773-1784.
41. Lin WJ, Zheng X, Lin CC, Tsao J, Zhu X, Cody JJ, Coleman JM, Gherzi R, Luo M, Townes TM, Parker JN, Chen CY. 2011. Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection. Mol Cell Biol 31(16):3196-3207.
42. Linker K, Pautz A, Fechir M, Hubrich T, Greeve J, Kleinert H. 2005. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res 33(15):4813-4827.
43. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21(19):6461-6469.
44. Marie I, Durbin JE, Levy DE. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 17(22):6660-6669.
45. Min H, Turck CW, Nikolic JM, Black DL. 1997. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev 11(8):1023-1036.
46. Nechama M, Ben-Dov IZ, Briata P, Gherzi R, Naveh-Many T. 2008. The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels. FASEB J 22(10):3458-3468.
47. Paste M, Huez G, Kruys V. 2003. Deadenylation of interferonbeta mRNA is mediated by both the AU-rich element in the 3¢-untranslated region and an instability sequence in the coding region. Eur J Biochem 270(7):1590-1597.
48. Raj NB, Pitha PM. 1981. Analysis of interferon mRNA in human fibroblast cells induced to produce interferon. Proc Natl Acad Sci USA 78(12):7426-7430.
49. Raj NB, Pitha PM. 1993. 65-kDa protein binds to destabilizing sequences in the IFN-beta mRNA coding and 3¢ UTR. FASEB J 7(8):702-710.
50. Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, Affabris E. 2002. IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 22(1):39-47.
51. Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, McManus MT, Rosenfeld MG, Briata P, Gherzi R. 2009. LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J 23(9):2898-2908.
52. Ruggiero T, Trabucchi M, Ponassi M, Corte G, Chen CY, al-Haj L, Khabar KS, Briata P, Gherzi R. 2007. Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling. BMC Mol Biol 8:28.
53. Sanduja S, Blanco FF, Dixon DA. 2011. The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdiscip Rev RNA 2(1):42-57.
54. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13(4):539-548.
55. Sauer I, Schaljo B, Vogl C, Gattermeier I, Kolbe T, Muller M, Blackshear PJ, Kovarik P. 2006. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 107(12):4790-4797.
56. Schmidt N, Pautz A, Art J, Rauschkolb P, Jung M, Erkel G, Goldring MB, Kleinert H. 2010. Transcriptional and posttranscriptional regulation of iNOS expression in human chondrocytes. Biochem Pharmacol 79(5):722-732.
57. Sofroniew MV, Vinters HV. 2010. Astrocytes: biology and pathology. Acta Neuropathol 119(1):7-35.
58. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25(3):373-381.
59. Stoecklin G, Anderson P. 2006. Posttranscriptional mechanisms regulating the inflammatory response. Adv Immunol 89:1-37.
60. Sundaram GM, Common JE, Gopal FE, Srikanta S, Lakshman K, Lunny DP, Lim TC, Tanavde V, Lane EB, Sampath P. 2013. 'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature 495(7439):103-106.
61. Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka N, Taniguchi T. 2000. Cross talk between interferon-gamma and-alpha/beta signaling components in caveolar membrane domains. Science 288(5475):2357-2360.
62. Taylor GA, Thompson MJ, Lai WS, Blackshear PJ. 1995. Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J Biol Chem 270(22):13341-13347.
63. Thompson MR, Xu D, Williams BR. 2009. ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med (Berl) 87(11):1053-1060.
64. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A, Gherzi R, Rosenfeld MG. 2009. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459(7249):1010-1014.
65. van Heuvel M, Bosveld IJ, Luyten W, Trapman J, Zwarthoff EC. 1986. Transient expression of murine interferon-alpha genes in mouse and monkey cells. Gene 45(2):159-165.
66. Wan G, Zhang X, Langley RR, Liu Y, Hu X, Han C, Peng G, Ellis LM, Jones SN, Lu X. 2013. DNA-damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathway. Cell Rep 3(6):2100-2112.
67. Whittemore LA, Maniatis T. 1990. Postinduction turnoff of betainterferon gene expression. Mol Cell Biol 10(4):1329-1337.
68. Wilusz CJ, Wilusz J. 2004. Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet 20(10):491-497.
69. Wilusz CJ,WormingtonM, Peltz SW. 2001. The cap-to-tail guide to mRNA turnover. Nat Rev Mol Cell Biol 2(4):237-246.
70. Winzen R, Thakur BK, Dittrich-Breiholz O, Shah M, Redich N, Dhamija S, Kracht M, Holtmann H. 2007. Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets. Mol Cell Biol 27(23):8388-8400.
71. Zhang X, Wan G, Berger FG, He X, Lu X. 2011. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell 41(4):371-383.
72. Zhou R, Gong A-Y, Eischeid AN, Chen X-M. 2012. miR-27b targets KSRP to coordinate TLR4-mediated epithelial defense against Cryptosporidium parvum infection. PLoS Pathog 8(5):e1002702.